• No results found

University of Groningen Beyond risk-reducing salpingo-oophorectomy Fakkert, Ingrid Elizabeth

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Beyond risk-reducing salpingo-oophorectomy Fakkert, Ingrid Elizabeth"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Beyond risk-reducing salpingo-oophorectomy

Fakkert, Ingrid Elizabeth

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Fakkert, I. E. (2017). Beyond risk-reducing salpingo-oophorectomy: On breast cancer risk and bone health. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Beyond risk-reducing

salpingo-oophorectomy

On breast cancer risk and bone health

(3)

ISBN: 978-94-034-0077-8 (printed version) 978-94-034-0076-1 (digital version) Cover design: Ilse Schrauwers, isontwerp.nl Layout & printing: Ridderprint BV, Ridderkerk © Copyright: Ingrid E. Fakkert, 2017

All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system or transmitted in any form or by any means without prior permission of the author and the publisher holding the copyright of the published articles.

The research described in this thesis was supported by a Junior Scientific Masterclass MD/PhD grant of the Graduate School of Medical Sciences Groningen. Part of this research was supported with unrestricted grants provided by Amgen, Menarini, Nycomed and Willpharma. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the chapters in this thesis.

(4)
(5)

Promotores

Prof. dr. M.J.E. Mourits Prof. dr. G.H. de Bock

Copromotor

Dr. J.C. Oosterwijk

Beoordelingscommissie

Prof. dr. J.P. van den Bergh Prof. dr. ir. F.E. van Leeuwen Prof. dr. R.H. Sijmons

(6)

Paranimfen

Heleen F. Fakkert Stefan M. Wierda

(7)
(8)

Content

Chapter 1 General introduction 9

Part I: Risk-reducing salpingo-oophorectomy and breast cancer risk Chapter 2 Breast cancer screening in BRCA1 and BRCA2 mutation

carriers after risk-reducing salpingo-oophorectomy

Breast Cancer Res Treat 2011;129:157-64

31

Chapter 3 Breast cancer incidence after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers

Cancer Prev Res (Phila) 2012;5:1291-7

45

Part II: Risk-reducing salpingo-oophorectomy and bone health Chapter 4 Bone mineral density and fractures after surgical

menopause: a systematic review and meta-analysis

BJOG 2017;124:1525-35

61

Chapter 5 Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer

Eur J Cancer 2015;51:400-8

119

Chapter 6 Elevated bone turnover markers after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer

PLoS One 2017;12:e0169673

143

Chapter 7 Summary and general discussion 165

Chapter 8 Nederlandse samenvatting 185

Appendices References 194

Dankwoord 218

(9)

Referenties

GERELATEERDE DOCUMENTEN

This thesis entitled ‘Beyond risk-reducing salpingo-oophorectomy: on breast cancer risk and bone health’ aims to increase knowledge of the effects of premenopausal

In this group of 139 BRCA1/2 mutation carriers who had had RRSO at a premenopausal age and were under surveillance at our Family Cancer Clinic, 14 breast cancers were detected in

Although it has been shown that short-term use of hormonal replacement therapy does not negate the effect of RRSO and one study found an inversed relation in hormonal

Sensitivity analyses show no significant differences in BMD in three studies including women with similar age at or time since surgical or natural menopause, but lower BMD

This study aimed to compare BMD and fracture incidence after RRSO before menopausal age in an unselected consecutive series of BRCA1/2 mutation carriers and women with a

In univariate regression analyses, Z-scores for all BTMs were significantly higher in women aged ≤ 50 years compared to women aged > 50, which is in line with the finding that

for fractures that are specific for BRCA1/2 mutation carriers, including breast cancer treatment, can be studied in more the detail in a larger study population with

Deze hypothese wordt ondersteund door observaties dat andere risicofactoren die samenhangen met oestrogenen, zoals lichaamsgewicht, hormonale suppletie therapie (HST) en